VENTANA CLDN18 (43-14A) RxDx Assay

Immunohistochemistry - gastrointestinal tract carcinoma markers · class III · Until 02/10/2033

Registration no.
10287411677
Process no.
25351409793202374
Status
Until 02/10/2033
Device type
Immunohistochemistry - gastrointestinal tract carcinoma markers (IMUNOHISTOQUÍMICA - MARCADORES DE CARCINOMAS DO TRATO GASTRINTESTINAL)
Risk class
III
Registration holder
ROCHE DIAGNÓSTICA BRASIL LTDA CNPJ 30.280.358/0001-86 · 1,784 registrations
Manufacturer
VENTANA MEDICAL SYSTEM, INC · United States
Published
02/10/2023
Valid until
02/10/2033
Last updated by ANVISA
2026-10-12
Official record
View on ANVISA ↗

Other immunohistochemistry - gastrointestinal tract carcinoma markers registrations (7 in total, see all)

ProductClass HolderPublishedStatus
Família de Marcadores de Carcinomas do Trato Gastrintestinal CM I
10287411784
III ROCHE DIAGNÓSTICA BRASIL LTDA 06/04/2026 Until 06/04/2036
Família Anticorpo para Carcinoma Gastrointestinal
10337990044
III LEICA DO BRASIL IMPORTAÇÃO E COMÉRCIO LTDA. 03/11/2020 Until 03/11/2030
FAMÍLIA MARCADOR DE CARCINOMA DO TRATO GASTROINTESTINAL
80000230035
III AGILENT TECHNOLOGIES BRASIL LTDA 26/12/2016 Until 17/03/2034
Família de Marcador de Carcinoma do Trato Gastrointestinal
80000230038
III AGILENT TECHNOLOGIES BRASIL LTDA 26/12/2016 Until 10/03/2034
Família Tumor Gastrointestinal_Cell Marquee - Roche
10287410858
III ROCHE DIAGNÓSTICA BRASIL LTDA 25/02/2010 Until 25/02/2035
Familia Tumor Gastrointestinal
10287410797
III ROCHE DIAGNÓSTICA BRASIL LTDA 01/06/2009 Until 01/06/2034